Novocure Ltd (NASDAQ:NVCR)
| 69.76 Delayed Data As of May 18 |  -1.96 / -2.73%Today’s Change | 56.51 Today|||52-Week Range 232.76 | -7.09% Year-to-Date |
Latest NVCR News | Press Releases
| Nasdaq Bear Market: 3 Great Stocks to Buy That Are Down 50% or More May 11 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 71.69 |
| Today’s open | 70.00 |
| Day’s range | 68.40 - 71.79 |
| Volume | 472,038 |
| Average volume (3 months) | 663,745 |
| Market cap | $6.8B |
Data as of 4:01pm ET, 05/18/2022
Growth & Valuation
| Earnings growth (last year) | -387.51% |
| Earnings growth (this year) | +2.90% |
| Earnings growth (next 5 years) | +13.00% |
| Revenue growth (last year) | +8.23% |
| P/E ratio | NM |
| Price/Sales | 14.51 |
| Price/Book | 16.52 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| MASIMasimo Corp | -3.13 | -2.24% |
| TNDMTandem Diabetes Care... | -3.17 | -4.24% |
| IRTCiRhythm Technologies... | -7.53 | -5.66% |
| LIVNLivaNova PLC | -2.18 | -3.27% |
Data as of 4:01pm ET, 05/18/2022
Financials
| Next reporting date | July 28, 2022 |
| EPS forecast (this quarter) | -$0.15 |
| Annual revenue (last year) | $535.0M |
| Annual profit (last year) | -$58.4M |
| Net profit margin | -10.91% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters St. Helier, Jersey |
Forecasts
